Analysis of the SARS-CoV-2 spike protein revealed that blocked receptor-binding domain antigenicity decreases the production of neutralizing antibodies in vivo https://www.biorxiv.org/content/10.1101/2023.02.23.529497v1?med=mas
Analysis of the SARS-CoV-2 spike protein revealed that blocked receptor-binding domain antigenicity decreases the production of neutralizing antibodies in vivo https://www.biorxiv.org/content/10.1101/2023.02.23.529497v1?med=mas